How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

13,775 results for

Ages and Stages Questionnaire

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)

Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) (IBBR) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read

2018 Clinical Trials

42. A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer (...) to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer The safety and scientific validity of this study is the responsibility

2018 Clinical Trials

43. One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty

One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. One-stage Versus (...) Two-stage Revision of the Infected Knee Arthroplasty The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03435679 Recruitment Status : Recruiting First Posted : February 16, 2018 Last Update Posted : March 6, 2018 See

2018 Clinical Trials

44. Interventions for anxiety in mainstream school-aged children with autism spectrum disorder (ASD) Full Text available with Trip Pro

Interventions for anxiety in mainstream school-aged children with autism spectrum disorder (ASD) Interventions for anxiety in mainstream school‐aged children with autism spectrum disorder: A systematic review - Hillman - 2020 - Campbell Systematic Reviews - Wiley Online Library COVID-19 campus closures: see options for to subscribed content. By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open (...) Access Interventions for anxiety in mainstream school‐aged children with autism spectrum disorder: A systematic review Corresponding Author E-mail address: Australian Council for Educational Research, Camberwell, Victoria, Australia Correspondence Petra Lietz, Australian Council for Educational Research, 186B Pulteney Street, Adelaide, SA 5000, Australia. Email: Australian Council for Educational Research, Adelaide, South Australia, Australia Australian Council for Educational Research, Adelaide

2020 Campbell Collaboration

45. Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage. Full Text available with Trip Pro

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage. This study evaluated the clinical and non-clinical determinants of health-related quality of life (HRQoL) associated with untreated chronic hepatitis C (CHC) in France.From 01/2014 to 01/2015, untreated CHC patients were invited to complete a questionnaire including EQ-5D utility instrument and two visual analogue scales (VAS) measuring overall health (...) and fatigue in three French centers (Paris, Lille and Montpellier). Answers were analyzed in mixed models (taking into account the clustering effects of centers and physicians).Five hundreds and five patients were enrolled: 52% males; the mean age was 54; 41% had BMI>25; 64% had genotype 1; 36% were at the stage of severe fibrosis (F3-F4); 38% had severe comorbidities other than liver-related. In the univariate analysis, EQ-5D utility was associated with socio-demographic variables as age, place of birth

2019 PLoS ONE

46. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study. Full Text available with Trip Pro

of 20,501 parents (mothers and/or fathers) of schoolchildren from 11,396 families completed the Finnish Diabetes Risk Score (FINDRISC) questionnaire, while their children underwent anthropometric measurements in the school setting. Parents from the identified "high-risk families" (n = 4484) were invited to participate in the second-stage screening, including the measurement of fasting plasma glucose (FPG) and blood pressure (BP). In total, 3153 parents participated in the second-stage screening (mean (...) age 41.1 ± 5.6 years, 65.8% females).Among parents who attended the second-stage screening, the prevalence of prediabetes (as defined by impaired fasting glucose; FPG 100-125 mg/dl) and T2D (FPG > 126 mg/dl) was 23.2 and 3.0% respectively, and it was found to be higher in the higher FINDRISC categories. The percentage of undiagnosed T2D among the participants identified with T2D was 53.5%. The prevalence of high normal BP (systolic BP 130-139 mmHg and/ or diastolic BP 85-89 mmHg) and hypertension

2020 BMC Endocrine Disorders

47. Headache at the Chronic Stage of Ischemic Stroke. (Abstract)

). Characteristics of those headaches were collected using a previously validated headache questionnaire enabling headache classification following the International Headache Society criteria. Pre-stroke headache history was registered using the same instrument.Forty-five patients out of 89 with completed follow-up (51%) reported headache at the chronic stage. In most of the patients, headache was sporadic, mild, pressure-like, with a duration of minutes to hours, with characteristics of tension-type headache (...) in 51% (n = 23/45). Headache was a reactivation of pre-stroke headache in 33% (n = 15/45), different from pre-stroke headache in 44% (n = 20/45), and of new-onset in 22% (n = 10/45). Only 1 patient had a new-onset headache at the acute stage that persisted with the same characteristics at the chronic stage. Pre-stroke headache (OR = 5.3; 95% CI [2.01-13.98] P = .001) and female sex (OR = 3.5; 95% CI [1.3-9.4] P = .013) predicted headache at the chronic stage after stroke, controlling for age

2020 Headache

48. Intake of key micronutrients and food groups in patients with late-stage age-related macular degeneration compared with age-sex-matched controls. (Abstract)

Intake of key micronutrients and food groups in patients with late-stage age-related macular degeneration compared with age-sex-matched controls. Knowledge of the risk factor profile of patients presenting with late-stage age-related macular degeneration (AMD) could help identify the most frequent modifiable AMD precursors among people who are referred for treatment. We aimed to assess dietary behaviours by comparing adjusted mean intakes of micronutrients and major food groups (fruits (...) -frequency questionnaire. AMD lesions were assessed from retinal photographs.After multivariable adjustment, patients with late-stage AMD compared with controls had significantly lower intakes of vitamin E (7.4 vs 9.8 mg/day; p<0.0001), beta-carotene (6232 vs 7738 μg/day; p<0.0001), vitamin C (161 vs 184 mg/day; p=0.0002) and folate (498.3 vs 602 μg/day; p<0.0001); but had higher intakes of zinc (13.0 vs 11.9 mg/day; p<0.0001). A significantly lower proportion of patients with late AMD met

2016 British Journal of Ophthalmology

49. Validity of the ages and stages questionnaires in term and preterm infants. Full Text available with Trip Pro

Validity of the ages and stages questionnaires in term and preterm infants. This study assessed the concurrent validity of the parent-completed developmental screening measure Ages and Stages Questionnaires, Third Edition (ASQ-3) compared with the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) in children born term, late preterm, or extremely preterm at 8, 18, or 30 months of corrected gestational ages (CGA).Data were collected from 306 term and preterm children (...) ages 8, 18, and 30 months' CGA recruited from an ambulatory well-child clinic in Santiago, Chile. Parents completed the ASQ-3 in their homes, and afterward a trained professional administered the Bayley-III in a clinic setting. On the ASQ-3, the presence of any domain screened <2 SDs below the mean area score was considered a positive screen (indicating failure or delay). A Bayley-III score less than ≤1 SD indicated mild or severe delay.ASQ-3 showed adequate psychometric properties (75% sensitivity

2013 Pediatrics

50. The role of sentinel lymph node biopsy in the treatment of women with early stage vulval cancer: A summary of the evidence

with early stage vulval cancer: A systematic review. Sydney, 2014 9.Covens A, Vella ET, Kennedy EB, et al. Sentinel lymph node biopsy in vulvar cancer: Systematic review, meta-analysis and guideline recommendations. Gynecol Oncol. 2015;137(2):351-361 10.Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884-9 11.Oonk MH, van Os MA, de Bock GH, et al. A comparison of quality of life between vulvar cancer (...) The role of sentinel lymph node biopsy in the treatment of women with early stage vulval cancer: A summary of the evidence The role of sentinel lymph node biopsy in the treatment of women with early vulval cancer: A summary of the evidence Early-stage cancer of the vulva The International Federation of Gynaecology and Obstetrics (FIGO) categorises cancer of the vulva into stages, with early-stage (1A or 1B) defined as being confined to the vulva or perineum, with stromal invasion, and negative

2015 Cancer Australia

51. Left ventricular assist devices in the treatment of end-stage heart failure

– Survival of LVAD patients (by type of patient) BTC: bridge to candidacy; BTT: bridge to transplant; DT: destination therapy Source: INTERMACS registry, 2015 Q2 8 Left ventricular assist devices in the treatment of end-stage heart failure KCE Report 264Cs A better quality of life as well Patients who receive an LVAD also see a significant increase in their quality of life after the procedure, despite the possible complications (see section 2.2). This has been evaluated with various questionnaires (...) Left ventricular assist devices in the treatment of end-stage heart failure 2016 www.kce.fgov.be KCE REPORT 264Cs SYNTHESIS LEFT VENTRICULAR ASSIST DEVICES IN THE TREATMENT OF END-STAGE HEART FAILURE 2016 www.kce.fgov.be KCE REPORT 264Cs HEALTH TECHNOLOGY ASSESSMENT SYNTHESIS LEFT VENTRICULAR ASSIST DEVICES IN THE TREATMENT OF END-STAGE HEART FAILURE MATTIAS NEYT, ROOS LEROY, CARL DEVOS, HANS VAN BRABANDT KCE Report 264Cs Left ventricular assist devices in the treatment of end-stage heart

2016 Belgian Health Care Knowledge Centre

52. Electronic personal assessment questionnaire for vascular conditions (ePAQ-VAS): development and validity. (Abstract)

Electronic personal assessment questionnaire for vascular conditions (ePAQ-VAS): development and validity. This paper describes the development and validation of an electronic personal assessment questionnaire for vascular conditions (ePAQ-VAS) that captures the symptomatology, quality of life and clinically relevant data of patients presenting to vascular services.A two-stage survey was conducted in patients attending a tertiary vascular department. Patients completed the ePAQ-VAS remotely (...) online, or on site using an electronic tablet. In the first stage of the survey, the responses were used to perform confirmatory factor analysis to assess the construct validity and remove redundant items. The internal reliability of disease-specific scales was investigated. In the second stage of the survey, the acceptability, known-group validity, test-retest reliability, and responsiveness of ePAQ-VAS was assessed.In total, 721 patients completed ePAQ-VAS. Their mean(s.d.) age was 63·5(15·7) years

2020 British Journal of Surgery

53. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study Full Text available with Trip Pro

and validated chronic obstructive pulmonary disease questionnaire to increase the pre-test probability for chronic obstructive pulmonary disease diagnosis in subjects undergoing confirmatory spirometry. In 2005, we completed the Austrian Burden of Obstructive Lung Disease-study in 1258 subjects aged >40 years. Post-bronchodilator spirometry was performed, and non-reversible airflow limitation defined by FEV1/FVC ratio below the lower limit of normal. Questions from the Salzburg chronic obstructive pulmonary (...) obstructive pulmonary disease screening questionnaire was derived from the highly standardized Burden of Obstructive Lung Disease study. This validated and easy to use questionnaire can help to increase the efficiency of chronic obstructive pulmonary disease case-finding.QUESTIONNAIRE FOR PRE-SCREENING POTENTIAL SUFFERERS: Scientists in Austria have developed a brief, simple questionnaire to identify patients likely to have early-stage chronic lung disease. Chronic obstructive pulmonary disease (COPD

2017 NPJ primary care respiratory medicine

54. Ages and Stages Questionnaire

Ages and Stages Questionnaire Ages and Stages Questionnaire Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Ages and Stages (...) Questionnaire Ages and Stages Questionnaire Aka: Ages and Stages Questionnaire , ASQ Questionnaire From Related Chapters II. Indications Development screening for age 1 month up to 5.5 years old (19 questionnaires) III. Description Each questionnaire contains 6 questions each in 5 areas (30 questions total) Communication Gross motor Fine motor Problem solving Personal-social Each question asks if the child is performing the given skill Yes: 10 points Sometimes: 5 points Not yet: 0 points Matches well child

2015 FP Notebook

55. Ages and Stages Questionnaire Social Emotional

Ages and Stages Questionnaire Social Emotional Ages and Stages Questionnaire Social Emotional Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Ages and Stages Questionnaire Social Emotional Ages and Stages Questionnaire Social Emotional Aka: Ages and Stages Questionnaire Social Emotional , ASQ:SE Behavioral Questionnaire , ASQ:SE From Related Chapters II. Indications Behavioral Screening in preschool children III. Description Specific questionnaire for each age of administration: 6, 12, 18, 24, 30, 36, 48 and 60 months Questionnaire addresses 7 areas Self regulation Compliance Communication Adaptive functioning Autonomy Affect

2015 FP Notebook

56. Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)

LSM Least squares mean LSMD Least squares mean difference MA Marketing authorisation MAH Marketing authorisation holder MD Mean difference MeSH Medical Subject Headings nAMD Neovascular age-related macular degeneration NA Not applicable NEI VFQ-25 National Eye Institute Visual Function Questionnaire-25 NMA Network meta-analysis NR Not reported OR Odds ratio QxW Every x weeks QoL Quality of life PCV Polypoidal choroidal vasculopathy PTJA09 - Brolucizumab for patients with neovascular (wet) AMD (...) factor to the projected increase in nAMD prevalence, with the proportion of the population aged =60 years anticipated to increase and account for 35% of the population in Europe by 2050 (40). The estimated incidence of late AMD in Europe in 2013 was between 2.9 and 3.7 per 1000 person-years (6). 1.1.3 Symptoms and burden of the disease The early and intermediate stages of AMD usually occur without symptoms, with minimal or no vision loss. As the disease progresses into late AMD, the symptoms of nAMD

2020 EUnetHTA

57. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

to deter- mine the quality of evidence and strength of recommendation (Box 1). The evidence-to-decision framework is provided in Appendix 2 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/ cmaj.171430/-/DC1). The Knowledge Translation team at St. Michael’s Hospital (Toronto, Ontario) engaged members of the public on behalf of the task force at two stages of guideline development. In the first phase, 15 participants aged 58 to 78 years rated outcomes to inform the systematic review, by means (...) Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings E588 CMAJ | MAY 14, 2018 | VOLUME 190 | ISSUE 19 © 2018 Joule Inc. or its licensors I mpaired vision is an important health burden in both devel- oped and developing countries, particularly among older adults. 1 The 2006 Participation and Activity Limitation Survey found that 13% of Canadians aged 75 years and older had a “see- ing limitation,” with 31% described as severe, compared

2018 CPG Infobase

58. Tiotropium (Spiriva Respimat) add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma

Tiotropium (Spiriva Respimat) add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma Tiotropium (Spiriva ® Respimat ® ). Reference number 1882. Page 1 of 3 AWMSG Secretariat Assessment Report – Limited submission Tiotropium (Spiriva ® Respimat ® ) 2.5 microgram, inhalation solution Company: Boehringer Ingelheim Ltd Licensed indication under consideration: add-on maintenance bronchodilator treatment in patients aged 6 years to < 18 years with severe (...) -on maintenance bronchodilator treatment in adult patients with asthma who are currently treated with the maintenance combination of inhaled corticosteroids (= 800 micrograms budesonide per day or equivalent) and long-acting ß2 agonists and who experienced one or more severe exacerbations in the previous year. This submission covers the licence extension to include patients aged 6 years to < 18 years. The whole licenced indication wording was revised at the time of the paediatric licence extension and is now

2018 All Wales Medicines Strategy Group

59. Using a bath or pool during first stage labour: A decision aid for women having a vaginal birth

Questionnaire. Journal of Nursing Research, 14(3): p. 190-197. [5] Brown, S.T., D. Campbell, and A. Kurtz, Characteristics of labor pain at two stages of cervical dilation. Pain, 1989. 39(3): p. 289-295. [6] Gaston-Johansson, f., G. Fridh, and K. Turner-Norvell, Progression of labor pain in primiparas and multiparas. Nursing Research, 1988. 37(2): p. 86-90. [7] Lowe, N.K., The nature of labor pain. American Journal of Obstetrics and Gynecology, 2002. 186(5, Supplement 1): p. S16-S24. [8] National (...) Using a bath or pool during first stage labour: A decision aid for women having a vaginal birth Using a bath or pool during first stage labour: A decision aid for women having a vaginal birthThis decision aid has been written to support women who are wanting to have a vaginal birth to know what to expect and to have a say in making decisions about using a bath or pool during labour. This decision aid provides information about two options: 1. Not using a bath or pool during labour 2 Using

2015 EUnetHTA

60. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) Full Text available with Trip Pro

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) | Nephrology Dialysis Transplantation | Oxford (...) Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation May 2015 Article Contents Article Navigation Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) Guideline development group Search for other works by this author on: Henk Bilo Search for other works by this author on: Luis Coentrão Search

2015 European Renal Best Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>